ALISO VIEJO, Calif.—
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company focused on therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, has announced financial results for the first quarter ended March 31, 2024.
Read more...